Immediate Impact

1 by Nobel laureates 68 standout
Sub-graph 1 of 20

Citing Papers

Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
2024 Standout
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
2024 Standout
2 intermediate papers

Works of Andrew Hamer being referenced

Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
2020
Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia
2020

Author Peers

Author Last Decade Papers Cites
Andrew Hamer 619 392 214 41 1.1k
Helén Sjöland 275 689 77 54 1.1k
Dhruv Mahtta 333 472 109 69 980
F Sestier 286 776 122 33 1.3k
Sanjay Gandhi 506 222 236 63 999
Mike K. Palmer 709 508 223 25 1.3k
James Reed 343 413 115 40 1.3k
Lem Moyé 329 704 111 18 1.3k
Mette My Madsen 197 349 84 29 1.3k
Luqin Deng 261 281 129 55 907
Karin Henriksson 178 722 112 39 1.2k

All Works

Loading papers...

Rankless by CCL
2026